NEW DELHI, Dec 14: Drug firm Alembic Pharmaceuticals Friday said it has raised Rs 350 crore through allotment of non-convertible debentures (NCDs) on private placement basis.
“The NCD committee of Alembic Pharmaceuticals Ltd…Has allotted 1,500, 9 per cent rated unsecured listed redeemable non-convertible debentures (NCDs)… Aggregating to Rs 150 crore under tranche I,” Alembic Pharmaceuticals said in a regulatory filing.
The company said it has also allotted 2,000, 9 per cent rated unsecured listed redeemable NCDs…Aggregating to Rs 200 crore.
(PTI)
Follow our WhatsApp channel
